Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020;396:726–34.

Article  PubMed  Google Scholar 

Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol. 2000;190:117–25.

Article  CAS  PubMed  Google Scholar 

Hoque R, Sohail M, Malik A, et al. TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology. 2011;141:358–69.

Article  CAS  PubMed  Google Scholar 

Ferrero-Andres A, Panisello-Rosello A, Rosello-Catafau J, et al. NLRP3 inflammasome-mediated inflammation in acute pancreatitis. Int J Mol Sci. 2020;21:5386.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao L, Dong X, Gong W, et al. Acinar cell NLRP3 inflammasome and gasdermin D (GSDMD) activation mediates pyroptosis and systemic inflammation in acute pancreatitis. Br J Pharmacol. 2021;178:3533–52.

Article  CAS  PubMed  Google Scholar 

Sendler M, van den Brandt C, Glaubitz J, et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis. Gastroenterology. 2020;158(253–69): e14.

Google Scholar 

Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821–32.

Article  CAS  PubMed  Google Scholar 

Axelsson J, Norrman G, Malmstrom A, et al. Initiation of acute pancreatitis by heparan sulphate in the rat. Scand J Gastroenterol. 2008;43:480–9.

Article  CAS  PubMed  Google Scholar 

Liu H, Li Y, Wang L, et al. Aggravation of acute pancreatitis by heparan sulfate in mice. Scand J Gastroenterol. 2009;44:626–32.

Article  CAS  PubMed  Google Scholar 

Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014;289:35237–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferro V. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses. Expert Opin Ther Targets. 2013;17:965–75.

Article  CAS  PubMed  Google Scholar 

Haneklaus M, O’Neill LA, Coll RC. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Curr Opin Immunol. 2013;25:40–5.

Article  CAS  PubMed  Google Scholar 

Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787–91.

Article  CAS  PubMed  Google Scholar 

Juliana C, Fernandes-Alnemri T, Kang S, et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J Biol Chem. 2012;287:36617–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goodall KJ, Poon IK, Phipps S, et al. Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4. PLoS ONE. 2014;9: e109596.

Article  PubMed  PubMed Central  Google Scholar 

Johnson GB, Brunn GJ, Kodaira Y, et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol. 2002;168:5233–9.

Article  CAS  PubMed  Google Scholar 

Akbarshahi H, Axelsson JB, Said K, et al. TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated. J Transl Med. 2011;9:219.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li N, Zhou H, Wu H, et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 2019;24:101215.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao Y, Zhao C, Tai Y, et al. STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome. Redox Biol. 2023;62:102691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Yao L, Fu X, et al. Experimental acute pancreatitis models: history, current status, and role in translational research. Front Physiol. 2020;11:614591.

Article  PubMed  PubMed Central  Google Scholar 

Vlodavsky I, Singh P, Boyango I, et al. Heparanase: from basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat. 2016;29:54–75.

Article  PubMed  PubMed Central  Google Scholar 

Khamaysi I, Hamo-Giladi DB, Abassi Z. Heparanase in acute pancreatitis. Adv Exp Med Biol. 2020;1221:703–19.

Article  CAS  PubMed  Google Scholar 

Khamaysi I, Singh P, Nasser S, et al. The role of heparanase in the pathogenesis of acute pancreatitis: a potential therapeutic target. Sci Rep. 2017;7:715.

Article  PubMed  PubMed Central  Google Scholar 

Lei Y, Tang L, Liu S, et al. Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration. Microbiome. 2021;9:115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buczek-Thomas JA, Nugent MA. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury. J Biol Chem. 1999;274:25167–72.

Article  CAS  PubMed  Google Scholar 

Hietaranta A, Mustonen H, Puolakkainen P, et al. Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-kappaB. Biochem Biophys Res Commun. 2004;323:192–6.

Article  CAS  PubMed  Google Scholar 

Jaffray C, Yang J, Carter G, et al. Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery. 2000;128:225–31.

Article  CAS  PubMed  Google Scholar 

Geisler F, Algul H, Riemann M, et al. Questioning current concepts in acute pancreatitis: endotoxin contamination of porcine pancreatic elastase is responsible for experimental pancreatitis-associated distant organ failure. J Immunol. 2005;174:6431–9.

Article  CAS  PubMed  Google Scholar